Singapore Health Sciences Authority CEO John Lim On Piloting Adaptive Licensing: An Interview With PharmAsia News (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Singapore could serve as a testing ground for adaptive licensing, thanks to its developed postmarketing surveillance system. But first it needs a drug candidate.